Mehmet Sarimahmut

Dr. Mehmet Sarimahmut

orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2013 in Bioorganic & Medicinal Chemistry
Verified
Journal Article
Closed access
MCMelis Debreli Coskun
Melis Debreli Coskun
FAFerda Ari
Ferda Ari
AOArzu Yilmaztepe Oral
Arzu Yilmaztepe Oral
MSMehmet Sarimahmut
Mehmet Sarimahmut
HKHatice M. Kutlu
Hatice M. Kutlu
EUEngin Ulukaya
Engin Ulukaya

2 August 2011 in Journal of Cancer Research and Clinical Oncology
Verified
Journal Article
Closed access
PDF file
EUEngin Ulukaya
Engin Ulukaya
FAFerda Ari
Ferda Ari
KDKonstantinos Dimas
Konstantinos Dimas
MSMehmet Sarimahmut
Mehmet Sarimahmut
EGEmel Guney
Emel Guney
VYVeysel T. Yilmaz
Veysel T. Yilmaz

1 February 2017 in Biochimica et Biophysica Acta (BBA) - General Subjects
Verified
Journal Article
Closed access
SASeyma Aydinlik
Seyma Aydinlik
MEMerve Erkisa
Merve Erkisa
BCBuse Cevatemre
Buse Cevatemre
MSMehmet Sarimahmut
Mehmet Sarimahmut
EDEgemen Dere
Egemen Dere
EUEngin Ulukaya
Engin Ulukaya

1 November 2015 in Journal of Inorganic Biochemistry
Verified
Journal Article
Closed access
CICeyda Icsel
Ceyda Icsel
VYVeysel T. Yilmaz
Veysel T. Yilmaz
YKYunus Kaya
Yunus Kaya
SDSelvi Durmus
Selvi Durmus
MSMehmet Sarimahmut
Mehmet Sarimahmut
EUEngin Ulukaya
Engin Ulukaya

1 June 2013 in Bioorganic & Medicinal Chemistry
Verified
Journal Article
Closed access
FAFerda Ari
Ferda Ari
EUEngin Ulukaya
Engin Ulukaya
MSMehmet Sarimahmut
Mehmet Sarimahmut
VYVeysel T. Yilmaz
Veysel T. Yilmaz

1 July 2013 in Anti-Cancer Drugs
Verified
Journal Article
Closed access
BCBuse Cevatemre
Buse Cevatemre
FAFerda Ari
Ferda Ari
MSMehmet Sarimahmut
Mehmet Sarimahmut
AOArzu Y. Oral
Arzu Y. Oral
EDEgemen Dere
Egemen Dere
EUEngin Ulukaya
Engin Ulukaya
The outcome in patients with breast cancer is not satisfactory to date, although new chemotherapy regimens have been introduced in clinics. Therefore, novel approaches are required for better management of patients with breast cancer. In this study, we tested the cytotoxic activity of a new combination of fenretinide, a synthetic retinoid, with indole-3-carbinol, a natural product present in vegetables such as broccoli and cabbage, against MCF-7 (estrogen receptor-positive) and MDA-MB-231 (estrogen receptor-negative) cell lines. It has been found that the combination resulted in more powerful cytotoxic activity, by induction of apoptosis, compared with that when they were used singly. In conclusion, this novel combination warrants in-vivo experiments to elucidate its possible use in the treatment of breast cancer.